Loading
Journal of Cancer Immunology
ISSN: 2689-968X
Volume 7, Issue 1, p1-44
Articles published in this issue are Open Access and licensed under Creative Commons Attribution License (CC BY NC) where the readers can reuse, download, distribute the article in whole or part by mentioning proper credits to the authors.
Exogenous Heat Shock Proteins HSPA1A and HSPB1 Interact with TLR2, TLR4, TLR5, and TLR7 on Differentiated U937 Monocytic Cells
Biological cells are sensitive to both pathological and non-pathological stress, which can activate the innate immune response. This activation often involves the release of heat shock proteins (HSPs), such as HSPA1A and HSPB1. However, the implications and relationships between HSP release and immune system activation remain unclear. While evidence suggests that HSPs play a role in immune system activation and regulation, their immune regulatory characteristics are still debated.
J Cancer Immunol, 2025, Volume 7, Issue 1, p1-14 | DOI: 10.33696/cancerimmunol.7.099
Immunotherapy in MSS/pMMR Metastatic Colorectal Cancer – Insights from the KEYNOTE-651
Microsatellite stable (MSS)/mismatch repair-proficient (pMMR) colorectal cancer (CRC) accounts for the majority of CRC cases and generally respond poorly to immunotherapy alone. This mini-review integrates findings from the KEYNOTE-651 study with current knowledge of frontline immunotherapy in MSS/pMMR metastatic CRC and explores the implications for clinical practice and future research directions.
J Cancer Immunol, 2025, Volume 7, Issue 1, p15-19 | DOI: 10.33696/cancerimmunol.7.100
Mechanisms and Clinical Implications of Immune Checkpoint Inhibitors PD-1, CTLA-4, and TIM-3 in Cancer
Cancer poses a significant health challenge due to its complex nature and the limitations of current treatments. Over the last decade, emerging research has identified that modulation of immune checkpoint molecules such as CTLA-4, PD-1, and TIM-3 can have potential therapeutic benefits. These molecules are critical regulators of the immune system’s ability to target and eliminate cancer cells. This review explores the roles of these immune checkpoints in cancer and hematological malignancies; examining their mechanisms of action and the potential they hold for enhancing therapeutic outcomes.
J Cancer Immunol, 2025, Volume 7, Issue 1, p20-29 | DOI: 10.33696/cancerimmunol.7.101
Sexual Dimorphism in Immunity and Metabolism: Unraveling the Impact on Response to Cancer Immunotherapy
A recent observational study by Jin et al., found male sex and pretreatment weight loss to be associated with worse progression free survival (PFS) and overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibition (ICI) [1]. Although sexual dimorphism in immunity is well established, recent studies have begun to elucidate the mechanisms by which sex-specific immunity contributes to diseases such as cancer, and autoimmunity [2-5]. Similarly, the complex interplay between gonadal hormones, sex-based gene expression, and metabolism, particularly immunometabolism and the subsequent ability to mount effective antitumor immunity is a burgeoning field of investigation.
J Cancer Immunol, 2025, Volume 7, Issue 1, p30-38 | DOI: 10.33696/cancerimmunol.7.102
Epigenetic Reprogramming with DNMT Inhibitors: A Multi-Mechanistic Approach to Enhance Immunotherapy in Glioblastoma
Although adoptive T cell therapies and immune checkpoint blockades have been successfully implemented in various cancers, no immunotherapy agents have yet reached FDA approval for glioblastoma (GBM). GBM harbors a uniquely immunosuppressive tumor microenvironment that presents significant barriers to effective immunotherapy. Key hallmarks of the GBM microenvironment include the exclusion of lymphoid cells from the tumor core and the predominance of immunosuppressive tumor-associated macrophages .
J Cancer Immunol, 2025, Volume 7, Issue 1, p39-44 | DOI: 10.33696/cancerimmunol.7.103
Chimeric Antigen Receptor CAR NK Cells Emerging Immunotherapy for the Treatment of Cancer
Although NK cells are recognized as effector lymphocytes of the innate immune system, they also regulate the adaptive immune response by releasing inflammatory cytokines and developing immunological memory. Unlike other lymphocytes such as T or B cells, NK cells do not express rearrangeable, antigen-specific receptors.
Emerging Role of TRPML1 Mucolipin Endolysosomal Channel in Cancer
The transient receptor potential mucolipin 1 (TRPML1) is an endolysosomal channel belonging to the TRP family. Clinically, mutations of TRPML1 have been responsible for a severe lysosomal storage disorder called mucolipidosis type IV.
Circulating Cell-Free RNA: A New Perspective for Endometrial Cancer
In order to implement the knowledge of cancer to monitor its evolution and setting, in the last decade, new minimally invasive and repeatable samples collection have been developed such as liquid biopsy. Cancer biomarkers originating from tumors can represent the molecular status of the tumor or its metastases which release them directly into body fluids or indirectly due to disruption of tumor/metastatic tissue. These biomarkers are detectable in liquid biopsy.
Searching for Easy Reliable Prognostic Parametres in Colorectal Cancer Patients Evaluation
Tumor node metastasis (TNM) staging system is the most useful method in predicting prognosis of colorectal cancer (CRC), the third most common cause of death worldwide, even if other biological markers are currently under evaluation to assess their role in affecting CRC outcome and planning the best tailored therapeutic approach. Several molecular factors are being demonstrated to be effective in influencing both overall survival (OS) and disease-free survival (DFS) in CRC, acting on different aspects of tumor promoting and progression.
Deubiquitinase as Potential Targets for Cancer Immunotherapy
During the last few decades, immunotherapy is considered to be an important approach to help our immune system to fight various kinds of diseases, such as tumor. Sometimes, it works very well for some types of cancers, for example: bladder cancer, colorectal cancer, breast cancer and lymphoma.
The Effect of Glucocorticoids on Angiogenesis in the Treatment of Solid Tumors
Glucocorticoids (GCs) are defined by their role in maintaining glucose homeostasis and natural GCs are a class of corticosteroids secreted by the adrenal cortex. Cortisol is the most important natural GC in humans. Cellular cortisol levels are regulated by the tissue-specific metabolic enzymes 11β-hydroxysteroid dehydrogenase 1 and 2 (11β-HSD 1 and 2); 11β-HSD 1 converts inactive cortisone to active cortisol, while 11β-HSD 2 has the opposite function.
Role of the Gut Microbiome in the Modulation of Cancer Immunotherapy Response
The gut microbiome or gut flora is a vast community of microorganisms such as bacteria, viruses, protozoa, and fungi that inhabit the digestive tract of the human and other animals. In the human body, bacterial species colonize into the oral cavity, skin, vagina, and placenta, however, the largest population of microorganisms resides in the intestine. The majority of gut microbiota belong to the phyla Firmicutes, Bacteroidetes, Proteobacteria and Actinobacteria.
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer
Breast cancer is the second most common cancer worldwide, affecting nearly one in eight women. Accurate cancer staging is essential for determining the patient’s prognosis and for choosing the appropriate treatment. The staging system most often used is the American Joint Committee on Cancer (AJCC) TNM system, where T refers to the size of the tumor, N refers to spread of the primary cancer to nearby lymph nodes, and M refers to the spread of metastasis to distant sites in the body.
Platelet Hyperactivity and Dysfunction in Diabetes and Cancer
However, the entire coagulation cascade is dysfunctional, in progressed chronic diabetes and cancer patients. Platelets (PLTs) in type 2 diabetic (DT2) involved in Thrombosis and Haemostasis (T&H) of individuals adhere to vascular endothelium and aggregate more voluntarily than those in healthy individuals, as are abnormalities in the microvascular and macrovascular circulations. However it is already known that the circulating PLTs are essential for T&H, inflammation growth factors delivery, regeneration; and knowledge of their function is fundamental to understanding the pathophysiology of vascular disease in diabetes and cancer-related diseases.
Safety and Efficacy of s-MOX Regimen in Patients with Colorectal Cancer Who Developed Cardiotoxicity Following Fluoropyrimidine Administration: A Case Series
Fluoropyrimidines compose the backbone of regimens to treat many common solid tumors, including gastrointestinal (GI), breast and head/neck. As we continue to use these agents routinely, recognition of rare but real toxicities, such as cardiotoxicity, has also improved. The treatment options for patients who have encountered fluoropyrimidine-induced cardiotoxicity are limited as many anti-angiogenic drugs also pose a cardiac risk.
SorLA Targeting - A Method to Overcome Therapy Resistance in Breast Cancer
In breast cancer, tyrosine kinase-type cell surface receptor HER2-targeted therapies do not achieve a sustained inhibition of oncogenic signaling. Therapy-resistant tumors compensate for HER2 inhibition through several mechanisms, including increased expression of other cell-surface receptors most notably HER3. HER3 remains currently undruggable despite extensive clinical efforts. Durable efficacy of HER2-based therapy regimens requires, therefore, effective inhibition of HER2 and HER3.
Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery in Stage 1B2 Cervical Cancer
In 2020 we published a series of 18 patients who underwent neoadjuvant chemotherapy (NACT) and vaginal radical trachelectomy (VRT) as a fertility sparing alternative in stage 1B2 cervical cancer.
CTLA-4 and PD-L1 or PD-1 Pathways: Immune Checkpoint Inhibitors and Cancer Immunotherapy
The immune system developed certain checks and balance to control or inhibit the reactivity against normal cells of the body. Uncontrolled immune responses to the non-self entities such as bacteria, viruses, parasites, or mutated self-antigens can cause an inflammatory reaction and autoimmune diseases.
Cancer Nanomedicine: Strategies to Enhance Tumor Delivery and Immunotherapy
Cancer nanomedicine was originally developed for more efficient delivery of chemotherapeutic agents into tumor, and has been extensively employed as a therapeutic for cancer treatment owing to its unique features in drug delivery, diagnosis and imaging, as well as the therapeutic nature of some nanomaterials themselves.
Relationship of lncRNA to Breast Cancer
At present, breast cancer is more frequently diagnosed in women than in men. According to global cancer statistics, each year more than 1,675,000 women are diagnosed and more than 500,000 of them die. Some subtypes of breast cancer have been described.
Targeting "Do Not Eat Me" Signal CD47 in Cancer Immunotherapy
Cells of the innate and adaptive arm of the immune system including macrophages, natural killer (NK) cells, neutrophils, T cells, and B cells, etc. are crucial for the maintenance of the body’s homeostatic balance and prevention of multiple diseases including cancer.
Kinetin/N6-furfuryladenine: A New Neurodegenerative Disease Lead from an Old Plant Cytokine
N6-fufuryladenine (N6FFA), or kinetin, has a long history as a plant cytokine with practical applications in agriculture. This adenosine analog is now commonplace in natural product small molecule chemical screening libraries, and as such has been discovered as active in mammalian disease pathways that include Parkinson’s disease, Huntington’s disease (HD) and Familial Dysautonomia.
Cellular Response to Stress: At the Crossroads between Immunosenescence and Cancer
Aging is a complicated process not yet fully understood. Driven by a variety of stressors such as infectious agents, radiation, intracellular stress, and stressing metabolic conditions, molecular damage occurs over time [1]. Among many consequences, age-related unchecked molecular damage leads to immunosenescence, a hallmark of aging. Traditionally defined as a declining function of the immune system, immunosenescence is a term that includes the effect of aging on adaptive and innate immunity [2].
COVID-19 Disease and SARS-CoV-2 Vaccination in Patients with Cancer
Since the declaration of COVID-19 as a pandemic in March 2020, there have been more than 100 million reported cases of COVID-19 worldwide and more than 2.1 million deaths. The purpose of this editorial is to review recent updates regarding COVID-19 disease and SARS-CoV-2 vaccination in cancer patients.
Inhibition of Autophagy and Immune Response: Alpha-fetoprotein Stimulates Initiation of Liver Cancer
Alpha-fetoprotein (AFP) is a tumorous marker for the diagnosis of hepatocellular carcinoma (HCC), it is synthesized mainly by the embryo yolk sac, fetal liver and the gastrointestinal tract. AFP belongs to the family of protein products of albuminoid genes, which are located in tandem arrangement in chromosome 4 (region 4q11-q13).
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.